Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3761 3781 3799
This examiner grants 75% of resolved cases
Leslie R. Deak is an examiner in Art Unit 3761 of Tech Center 3700. She has 956 resolved cases and an allowance rate of 75.3 percent. This 75.3 percent rate serves as a baseline for applicants to evaluate the probability of a grant. The 956 resolved cases represent the total volume of historical data available for this examiner.
The median time to allowance for applications in her portfolio is 1193 days. Practitioners should also note the interview lift of 17.8 percent. This 17.8 percent figure shows that applications involving an interview have a higher likelihood of allowance compared to those that do not. Within the 1193-day median pendency, an interview is a strategy that practitioners can use to move toward the 75.3 percent allowance rate in Art Unit 3761.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17845057 | SYSTEMS AND METHODS FOR PERCUTANEOUS BODY LUMEN DRAINAGE | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 18950289 | PACKAGED FEMININE HYGIENE PAD PRODUCT ADAPTED FOR DISCREET CARRY AND ACCESS, AND MANUFACTURING PROCESS | Non-Final OA | The Procter & Gamble Company |
| 18658669 | METHOD OF IMPLANTING AN OCULAR IMPLANT | Non-Final OA | Alcon Inc. |
| 18585332 | OCULAR IMPLANT AND DELIVERY SYSTEM | Final Rejection | Alcon Inc. |
| 18765980 | PUNCTURE NEEDLE AND METHOD OF USING GUIDE WIRE | Non-Final OA | OLYMPUS CORPORATION |
| 18629644 | PRESSURE-REGULATING VIAL ACCESS DEVICES | Non-Final OA | ICU Medical, Inc. |
| 18522058 | INTRAOCULAR IMPLANTS AND METHODS AND KITS THEREFOR | Non-Final OA | Sight Sciences, Inc. |
| 18739456 | SELF-SEALING CANNULA | Non-Final OA | University of Maryland, Baltimore |
| 18764739 | APPARATUS AND METHOD FOR REMOVING EXCESS TRANSTHYRETIN PROTEIN FROM BLOODSTREAM TO TREAT ATTR AMYLOIDOSIS | Non-Final OA | FLORIDA ATLANTIC UNIVERSITY BOARD OF TRUSTEES |
| 18259626 | FLUID COLLECTION ASSEMBLIES INCLUDING AT LEAST ONE NONWOVEN MATERIAL | Final Rejection | PureWick Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy